Johnson & Johnson’s medtech acquisitions over the past year have fueled growth for its cardiovascular group, offsetting ...

AcuityMD, a leading technology provider to the medical technology (MedTech) industry, today announced the launch of AcuityMD ...

TORONTO—While the FDA has already doled out green lights to about 950 medical devices backed by artificial intelligence or ...

The company also adopted the CBLL ticker, which has hovered around $25, during a dearth of medtech IPOs spanning several ...

Visakhapatnam: Union Minister of State for the Ministry of Skill Development and Entrepreneurship and Minister of State for ...

Event puts focus on medical technologies Oct. 15-17 at the Metro Toronto Convention Centre ...

Johnson & Johnson beat investors’ expectations despite its medtech unit underperforming, with execs pointing to the Asia-Pacific region as a continued source of struggle. Executives said on the ...

Matt Miksic, an analyst from Barclays, maintained the Hold rating on Johnson & Johnson (JNJ – Research Report). The associated price ...

Johnson & Johnson (NYSE: JNJ) shares dipped slightly before hours today on third-quarter financial results and a surgical ...

Johnson & Johnson's Q3 results exceeded expectations, with 26.5% year-over-year growth in the cardiovascular market and a 5.4 ...

Johnson & Johnson (JNJ) stock fell as the company lowered full-year earnings outlook while reporting better-than-expected Q3 ...

Hologic this week announced it signed a definitive agreement to acquire Gynesonics for approximately $350 million.